Shixie Xiang
Biographic Data
| ID | 7278846 |
|---|---|
| NAME | Shixie Xiang |
| GIVEN NAMES | Shixie |
| FAMILY NAME | Xiang |
| SIGNATURE | XIANG S |
| AFFILIATIONS | First Affiliated Hospital of Henan University |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Salvianolic acid C, a novel pyroptosis inhibitor, attenuates podocyte injury in diabetic kidney disease through regulating miRNA-21/A20 pathway
Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro
Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1
No prominent works on this page.
Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1
Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro
Salvianolic acid C, a novel pyroptosis inhibitor, attenuates podocyte injury in diabetic kidney disease through regulating miRNA-21/A20 pathway
Chronic Kidney Disease and Diabetes (2 works) · Kidney (2 works) · Kidney disease (2 works) · Pharmacology (2 works) · Apoptosis (1 works) · Biochemistry (1 works) · Biology (1 works) · Cell Biology (1 works) · Cholesterol and Lipid Metabolism (1 works) · Degradation (telecommunications (1 works)